Metabolic Concerns: Horses with insulin resistance or prone to laminitis may benefit from its regulatory effects on energy metabolism
This highlights the urgent need for adjunct neuroprotective therapies that can protect vulnerable brain tissue during and after treatment to maximise efficacy. Clinical trial demonstrates safety in severe LVO stroke patients Building on the teams multi-omics laboratory findings, the research team, led by Dr Bonaventure Ip Yiu-ming , Assistant Professor in the Department of Medicine and Therapeutics at CU Medicine, conducted the first Phase 2 randomised clinical trial to translate these biological insights into patient care
Alexander Shapsis, MD is a board-certified gastroenterologist and medical weight-loss specialist with extensive experience treating obesity and metabolic disorders using GLP-1 therapies, including semaglutide (Ozempic and Wegovy) and tirzepatide
Epithalon has shown promise in improving sleep quality and promoting longevity
Tolerability depends on the medication, dose, escalation schedule, individual biology, and how consistently you follow provider instructions
